Abivax SA ADR (NASDAQ:ABVX) shares rose 2.6% in premarket trading on Thursday after the clinical-stage biotechnology company announced that 22 scientific abstracts have been accepted for presentation ...

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on ...

Discusses Launch and Scientific Overview of OmniUltra Technology Platform December 15, 2025 5:00 PM ESTCompany ...

Lee University natural science students, Alexa VanVeghten and Karina Dilse, presented research posters at the 2025 Tennessee ...

Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced the company has been ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present eight posters at the American Epilepsy Society (AES) Annual Meeting, taking place Dec. 5-9 in ...

LONDON, December 03, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present eight posters at the American Epilepsy Society ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its participation in the International Surgical Sleep Society (ISSS) 2025 Annual Meeting in Indianapolis. The ...

Company studies continue to show durability and retention of benefits for patients receiving proximal hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea “Nearly 2 million ...

To support global participation, all posters will be available on-demand throughout the 2025 APS Global Psychological Science Summit event days, October 21-23, 2025. Poster presentations are not ...

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...